Sign in or register to see full information and data.

Publications / Lu 2020 (J Infect Dis)



J Infect Dis. 2020 Nov 13; 222(12):2093-2102.

PubMed ID: 32060529


Antibody Fc glycosylation discriminates between latent and active tuberculosis


Lu LL, Das J, Grace PS, Fortune SM, Restrepo BI, Alter G


Mycobacterium tuberculosis remains a global health problem and clinical management is complicated by difficulty in discriminating between latent infection and active disease. While M. tuberculosis-reactive antibody levels are heterogeneous, studies suggest that levels of IgG glycosylation differ between disease states. Here we extend this observation across antibody domains and M. tuberculosis specificities to define changes with the greatest resolving power.

With the publicly available data in the CAVD DataSpace we can Learn about studies, products, assays, antibodies, and publications, Find subjects with common characteristics, Plot assay results across studies and years of research, and Compare monoclonal antibodies and their neutralization curves. Data are also accessible via DataSpaceR, our R API.

Related Studies

No related studies